Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16234716rdf:typepubmed:Citationlld:pubmed
pubmed-article:16234716lifeskim:mentionsumls-concept:C0015426lld:lifeskim
pubmed-article:16234716lifeskim:mentionsumls-concept:C0000889lld:lifeskim
pubmed-article:16234716lifeskim:mentionsumls-concept:C0220908lld:lifeskim
pubmed-article:16234716lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:16234716lifeskim:mentionsumls-concept:C0205373lld:lifeskim
pubmed-article:16234716pubmed:issue5lld:pubmed
pubmed-article:16234716pubmed:dateCreated2005-10-19lld:pubmed
pubmed-article:16234716pubmed:abstractTextA 53-year-old man presented with thickening and hyperpigmentation of the eyelids. After the diagnosis of acanthosis nigricans was made, further investigation of a possible underlying disorder, including biochemical and instrumental examinations, indicated the presence of glucose intolerance, which had been diagnosed 3 years after the clinical appearance of acanthosis nigricans. Eyelid involvement in acanthosis nigricans is rare. Ophthalmologists should be aware of the possibility that acanthosis nigricans can exist in the periocular area and perform a systemic assessment of the patient for the presence of an underlying condition.lld:pubmed
pubmed-article:16234716pubmed:languageenglld:pubmed
pubmed-article:16234716pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16234716pubmed:citationSubsetIMlld:pubmed
pubmed-article:16234716pubmed:statusMEDLINElld:pubmed
pubmed-article:16234716pubmed:monthSeplld:pubmed
pubmed-article:16234716pubmed:issn0740-9303lld:pubmed
pubmed-article:16234716pubmed:authorpubmed-author:BoranCetinClld:pubmed
pubmed-article:16234716pubmed:authorpubmed-author:ParlakAli...lld:pubmed
pubmed-article:16234716pubmed:authorpubmed-author:GöksügürNadir...lld:pubmed
pubmed-article:16234716pubmed:authorpubmed-author:SerinDidemDlld:pubmed
pubmed-article:16234716pubmed:authorpubmed-author:AlagözGürsoyGlld:pubmed
pubmed-article:16234716pubmed:issnTypePrintlld:pubmed
pubmed-article:16234716pubmed:volume21lld:pubmed
pubmed-article:16234716pubmed:ownerNLMlld:pubmed
pubmed-article:16234716pubmed:authorsCompleteYlld:pubmed
pubmed-article:16234716pubmed:pagination403-4lld:pubmed
pubmed-article:16234716pubmed:meshHeadingpubmed-meshheading:16234716...lld:pubmed
pubmed-article:16234716pubmed:meshHeadingpubmed-meshheading:16234716...lld:pubmed
pubmed-article:16234716pubmed:meshHeadingpubmed-meshheading:16234716...lld:pubmed
pubmed-article:16234716pubmed:meshHeadingpubmed-meshheading:16234716...lld:pubmed
pubmed-article:16234716pubmed:meshHeadingpubmed-meshheading:16234716...lld:pubmed
pubmed-article:16234716pubmed:meshHeadingpubmed-meshheading:16234716...lld:pubmed
pubmed-article:16234716pubmed:year2005lld:pubmed
pubmed-article:16234716pubmed:articleTitleEyelid involvement in acanthosis nigricans: the importance of systemic screening.lld:pubmed
pubmed-article:16234716pubmed:affiliationDepartment of Ophthalmology, Izzet Baysal Medical Faculty, Bolu, Turkey. d_serin@yahoo.comlld:pubmed
pubmed-article:16234716pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16234716pubmed:publicationTypeCase Reportslld:pubmed